Although the coronavirus crisis is far from over, it has already transformed the way healthcare players operate. Some companies have seen record demand for their essential medicines, while others have only recently seen their revenues rebound after shutdowns and stay-at-home orders wreaked havoc on their business.
In spite of the ups and downs of the year, the timing has actually never been better for investors to get into the market. The top healthcare stocks in the S&P 500 index have returned between 23% and 96% year to date, making the benchmark's 6.6% rally look pretty measly.
In a market where winners keep winning and losers keep losing, the best way to ensure the safety of your capital is to buy stocks that are proven performers with future growth potential. Here are the 10 biggest healthcare winners in the S&P 500 index so far this year, and the reasons why they will enrich your portfolio for years to come.